Chugai Pharmaceutical to Run 3 Domestic Plants Instead of 2 (Japan)
This article was originally published in PharmAsia News
Executive Summary
Chugai Pharmaceutical Co. has decided to continue operating one of its plants in Japan it was initially planning to close, saying it will run three plants instead of two. The Tokyo-based pharmaceutical maker, part of the Roche Holding AG group, announced in 2005 it would concentrate its domestic production facilities into two plants from five plants. However, it has now decided not to close its Tokyo plant, which the company discovered has a longer-than-expected lifespan for the production of biological products. (Click here for more - May Require Paid Subscription
|
Chugai Pharmaceutical Co. has decided to continue operating one of its plants in Japan it was initially planning to close, saying it will run three plants instead of two. The Tokyo-based pharmaceutical maker, part of the Roche Holding AG group, announced in 2005 it would concentrate its domestic production facilities into two plants from five plants. However, it has now decided not to close its Tokyo plant, which the company discovered has a longer-than-expected lifespan for the production of biological products. (Click here for more - May Require Paid Subscription)
"Chugai Pharmaceutical to Run 3
Domestic Plants Instead of 2"
|